Charles River Laboratories CRL Canada — Total Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's canada — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Charles River Laboratories's canada — total revenue?
- Charles River Laboratories (CRL) reported canada — total revenue of $109.57M in Q1 2026.
- How has Charles River Laboratories's canada — total revenue changed year-over-year?
- Charles River Laboratories's canada — total revenue decreased by 12.6% year-over-year, from $125.35M to $109.57M.
- What is the long-term trend for Charles River Laboratories's canada — total revenue?
- Over 4 years (2021 to 2025), Charles River Laboratories's canada — total revenue has grown at a 10.3% compound annual growth rate (CAGR), from $339.1M to $501.03M.
- What does canada — total revenue mean?
- This metric represents the total gross income generated by the company's operations within the Canadian geographic segment. It reflects the demand for research models, services, and laboratory support provided to clients located in this specific region. Monitoring this figure helps assess the company's market penetration and regional growth performance relative to local pharmaceutical and biotechnology research activity.